Log in

Adamas Pharmaceuticals




GOCOVRI Clinical Information Visual Aid with PI

ISI March 2020 Update


INDICATION
GOCOVRI┬« (amantadine) extended release capsules is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications.



contact information

Monica Ammerman

Tel: 701-388-0867| Email: mammerman@adamaspharma.com

1900 Powell St. Suite 1000

Emeryville, CA 94608




Powered by Wild Apricot Membership Software